Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
15 11 2019
Historique:
received: 07 09 2018
revised: 13 06 2019
accepted: 09 10 2019
entrez: 16 11 2019
pubmed: 16 11 2019
medline: 18 4 2020
Statut: ppublish

Résumé

Myocarditis can develop into inflammatory cardiomyopathy through chronic stimulation of myosin heavy chain 6-specific T helper (T

Identifiants

pubmed: 31727837
pii: 366/6467/881
doi: 10.1126/science.aav3487
doi:

Substances chimiques

Myh6 protein, mouse 0
Peptides 0
beta-Galactosidase EC 3.2.1.23
Myosin Heavy Chains EC 3.6.4.1

Banques de données

figshare
['figshare.com/s/229fc19d6d8db36ad1db']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

881-886

Subventions

Organisme : Swiss National Science Foundation
Pays : Switzerland

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Cristina Gil-Cruz (C)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Christian Perez-Shibayama (C)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Angelina De Martin (A)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Francesca Ronchi (F)

Maurice Müller Laboratories, Department of Biomedical Research, Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Berne, Berne, Switzerland.

Katrien van der Borght (K)

VIB Center for Inflammation Research, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.

Rebekka Niederer (R)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Lucas Onder (L)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Mechthild Lütge (M)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Mario Novkovic (M)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Veronika Nindl (V)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Gustavo Ramos (G)

Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
Comprehensive Heart Failure Center, University Hospital of Würzburg, Würzburg, Germany.

Markus Arnoldini (M)

Institute of Food, Nutrition and Health, ETH, Zurich, Switzerland.

Emma M C Slack (EMC)

Institute of Food, Nutrition and Health, ETH, Zurich, Switzerland.

Valérie Boivin-Jahns (V)

Comprehensive Heart Failure Center, University Hospital of Würzburg, Würzburg, Germany.
Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.

Roland Jahns (R)

Comprehensive Heart Failure Center, University Hospital of Würzburg, Würzburg, Germany.
Interdisciplinary Bank of Biomaterials and Data Würzburg (IBDW), University Hospital of Würzburg, Würzburg, Germany.

Madeleine Wyss (M)

Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Catherine Mooser (C)

Maurice Müller Laboratories, Department of Biomedical Research, Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Berne, Berne, Switzerland.

Bart N Lambrecht (BN)

VIB Center for Inflammation Research, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.

Micha T Maeder (MT)

Cardiology Division, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Hans Rickli (H)

Cardiology Division, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Lukas Flatz (L)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Urs Eriksson (U)

Center for Molecular Cardiology University of Zurich, Zurich, Switzerland.
Department of Medicine, GZO Regional Health Center, Wetzikon, Switzerland.

Markus B Geuking (MB)

Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Kathy D McCoy (KD)

Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Burkhard Ludewig (B)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland. burkhard.ludewig@kssg.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH